Detalles de la búsqueda
1.
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
Brain
; 147(3): 849-857, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37936330
2.
Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review.
Drug Metab Rev
; 56(2): 164-174, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38655747
3.
Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis.
CNS Spectr
; 29(2): 150-154, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453677
4.
Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
Neurol Sci
; 45(4): 1335-1342, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321333
5.
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
Ann Gen Psychiatry
; 23(1): 10, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38424537
6.
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
Acta Neuropsychiatr
; : 1-7, 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38605630
7.
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia.
CNS Spectr
; 28(5): 541-560, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36268655
8.
The role of KCNQ channel activators in management of major depressive disorder.
J Affect Disord
; 359: 364-372, 2024 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772507
9.
A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.
J Affect Disord
; 350: 698-705, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244804
10.
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system.
Int Clin Psychopharmacol
; 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727416
11.
Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS).
Expert Opin Drug Saf
; : 1-5, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804896
12.
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review.
Expert Opin Pharmacother
; 25(4): 467-476, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515004
13.
Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled Trial.
medRxiv
; 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38562707
14.
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial.
medRxiv
; 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38562760
15.
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
J Affect Disord
; 355: 342-354, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570038
16.
Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis.
J Affect Disord
; 356: 684-698, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657767
17.
Associations between somatic symptoms and remission of major depressive disorder: A longitudinal study in China.
J Psychiatr Res
; 172: 382-390, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452636
18.
Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis.
Adv Ther
; 41(2): 686-695, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114867
19.
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
Adv Ther
; 41(5): 1983-1994, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520501
20.
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
Curr Med Res Opin
; : 1-7, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38860901